Which organisms are commonly co‑isolated with Escherichia coli in urinary tract infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Organisms Commonly Co-Isolated with E. coli in UTIs

E. coli is most commonly co-isolated with Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecalis, and Staphylococcus saprophyticus in urinary tract infections. 1

Primary Co-Pathogens

The bacterial landscape of UTIs shows a consistent pattern of organisms that accompany E. coli:

  • Klebsiella pneumoniae is the second most common uropathogen found alongside E. coli, particularly in complicated UTIs and healthcare-associated infections 1, 2

  • Proteus mirabilis frequently co-exists with E. coli, especially in patients with structural urinary tract abnormalities or catheter-associated infections 1

  • Enterococcus faecalis represents another common co-pathogen, particularly in polymicrobial infections and in patients with instrumentation or recent antibiotic exposure 1

  • Staphylococcus saprophyticus is commonly identified alongside E. coli, particularly in young sexually active women with uncomplicated cystitis 1

Clinical Context

While E. coli accounts for up to 90% of all UTIs in ambulatory populations as a single pathogen 3, when polymicrobial infections occur, the organisms listed above represent the most frequent co-isolates 1.

Important Considerations:

  • E. coli dominance: In most UTI cases, E. coli is the predominant organism even when other bacteria are present, with uropathogenic E. coli (UPEC) being the primary driver of infection 1

  • Antimicrobial resistance patterns: Co-infections with these organisms increasingly involve multidrug-resistant strains, particularly ESBL-producing Enterobacterales (E. coli and Klebsiella) 2

  • Treatment implications: When treating suspected polymicrobial UTIs, empiric coverage must account for both E. coli and these common co-pathogens, with consideration of local resistance patterns 2

Related Questions

What is the best treatment approach for an 85-year-old female with Escherichia coli (E. coli) urinary tract infection (UTI)?
What is the recommended treatment for a pregnant woman with an Escherichia coli (E. coli) urinary tract infection (UTI)?
What is the best oral antibiotic for a patient with Escherichia coli (E. coli) urinary tract infection (UTI)?
What is the safest antibiotic for a breastfeeding mother with a urinary tract infection (UTI) caused by E. coli sensitive to all antibiotics?
What is the recommended treatment for a patient with Escherichia coli (E. coli) urinary tract infection (UTI) with a colony count greater than 100,000?
What is the emergency management of severe hyperkalemia (serum potassium ≥6.0 mmol/L) with electrocardiographic changes, including membrane stabilization, intracellular potassium shift, potassium removal, and criteria for dialysis?
How can airway secretions be reduced in a patient with hepatic encephalopathy, pneumonia, and type 2 (hypercapnic) respiratory failure?
When should subclinical hypothyroidism be treated and what levothyroxine dosing regimen is recommended for adults, including older patients, those with cardiovascular disease, pregnancy, or symptoms, versus a watch‑and‑wait approach?
What is the appropriate management for a patient with a systolic blood pressure of 200 mm Hg presenting with headache while taking risperidone?
What is the recommended post‑treatment surveillance schedule—including clinic visit frequency, laboratory tests, imaging studies, cardiac echocardiography, audiometry, and renal monitoring—for an adolescent who has completed curative surgery and adjuvant chemotherapy for osteosarcoma?
Is piperacillin‑tazobactam plus metronidazole an appropriate empiric antibiotic regimen for an adult with a hepatic abscess and no known drug allergies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.